During
the development of a Friedel–Crafts acylation for
the preparation of a key pyrrole intermediate in the synthesis of
the HIV attachment inhibitor, BMS-663068-03, a significant scale dependence
was found. A precipitous drop in yield was observed for the acylation
of a protected pyrrole with chloroacetyl chloride upon scale-up. Spectroscopic
studies to mitigate this scale dependence led to the identification
of the complex effect of dissolved hydrogen chloride (HCl) as well
as the poor reactivity of the acylating agent, chloroacetyl chloride.
At this point, the counterintuitive choice to switch to a longer,
but scale-independent, three-step route was made. By changing the
acylating agent to acetyl chloride, a more robust process was obtained.
Rapid development of a high yielding α-chlorination then provided
the common α-chloroketone intermediate required to generate
the desired α-amide ketopyrrole. The improved yield and scalability
of this three-step process supported the addition of one linear step
to the route, and it was demonstrated successfully at scale.